1. Home
  2. CRVS vs AHH Comparison

CRVS vs AHH Comparison

Compare CRVS & AHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • AHH
  • Stock Information
  • Founded
  • CRVS 2014
  • AHH 1979
  • Country
  • CRVS United States
  • AHH United States
  • Employees
  • CRVS N/A
  • AHH N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • AHH Real Estate
  • Sector
  • CRVS Health Care
  • AHH Finance
  • Exchange
  • CRVS Nasdaq
  • AHH Nasdaq
  • Market Cap
  • CRVS 459.0M
  • AHH 543.5M
  • IPO Year
  • CRVS 2016
  • AHH 2013
  • Fundamental
  • Price
  • CRVS $8.79
  • AHH $6.44
  • Analyst Decision
  • CRVS Strong Buy
  • AHH Buy
  • Analyst Count
  • CRVS 4
  • AHH 4
  • Target Price
  • CRVS $13.75
  • AHH $8.13
  • AVG Volume (30 Days)
  • CRVS 1.0M
  • AHH 936.4K
  • Earning Date
  • CRVS 11-04-2025
  • AHH 11-03-2025
  • Dividend Yield
  • CRVS N/A
  • AHH 12.79%
  • EPS Growth
  • CRVS N/A
  • AHH N/A
  • EPS
  • CRVS N/A
  • AHH 0.19
  • Revenue
  • CRVS N/A
  • AHH $452,636,000.00
  • Revenue This Year
  • CRVS N/A
  • AHH N/A
  • Revenue Next Year
  • CRVS N/A
  • AHH $3.21
  • P/E Ratio
  • CRVS N/A
  • AHH $33.95
  • Revenue Growth
  • CRVS N/A
  • AHH N/A
  • 52 Week Low
  • CRVS $2.54
  • AHH $6.01
  • 52 Week High
  • CRVS $9.55
  • AHH $11.24
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 63.66
  • AHH 50.67
  • Support Level
  • CRVS $8.34
  • AHH $6.01
  • Resistance Level
  • CRVS $9.22
  • AHH $6.30
  • Average True Range (ATR)
  • CRVS 0.55
  • AHH 0.18
  • MACD
  • CRVS 0.01
  • AHH 0.02
  • Stochastic Oscillator
  • CRVS 83.41
  • AHH 82.00

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.

Share on Social Networks: